264 related articles for article (PubMed ID: 8319186)
1. Meningeal carcinomatosis from transitional cell carcinoma of the bladder.
Eng C; Cunningham D; Quade BJ; Schwamm L; Kantoff PW; Skarin AT
Cancer; 1993 Jul; 72(2):553-7. PubMed ID: 8319186
[TBL] [Abstract][Full Text] [Related]
2. [A case of carcinomatous meningitis from transitional cell carcinoma of the urinary bladder].
Hara Y; Kobayashi Y; Goto K; Tozuka K; Tokue A; Mochizuki M
Hinyokika Kiyo; 1994 Dec; 40(12):1113-7. PubMed ID: 7863865
[TBL] [Abstract][Full Text] [Related]
3. Transitional cell carcinomatous meningitis after M-VAC (methotrexate, vinblastine, doxorubicin, and cisplatin) chemotherapy.
Bishop JR; Moul JW; Maldonado L; McLeod DG
Urology; 1990 Oct; 36(4):373-7. PubMed ID: 2219624
[TBL] [Abstract][Full Text] [Related]
4. [Meningeal carcinomatosis as first manifestation of carcinoma of the bladder: report of 2 cases].
Juan Vidal O; de Paz Arias L; Catalá Barceló J; García Escrig M
An Med Interna; 2000 Aug; 17(8):425-8. PubMed ID: 11218991
[TBL] [Abstract][Full Text] [Related]
5. High incidence of brain metastases in patients treated with an M-VAC regimen for advanced bladder cancer.
Dhote R; Beuzeboc P; Thiounn N; Flam T; Zerbib M; Christoforov B; Debré B
Eur Urol; 1998; 33(4):392-5. PubMed ID: 9612683
[TBL] [Abstract][Full Text] [Related]
6. A case of brain and leptomeningeal metastases from urothelial carcinoma of the bladder.
Erhamamcı S; Reyhan M; Altinkaya N
Rev Esp Med Nucl Imagen Mol; 2014; 33(5):290-2. PubMed ID: 25043771
[TBL] [Abstract][Full Text] [Related]
7. Methotrexate, vinblastine, doxorubicin, and cisplatin for advanced transitional cell carcinoma of the urothelium. Efficacy and patterns of response and relapse.
Sternberg CN; Yagoda A; Scher HI; Watson RC; Geller N; Herr HW; Morse MJ; Sogani PC; Vaughan ED; Bander N
Cancer; 1989 Dec; 64(12):2448-58. PubMed ID: 2819654
[TBL] [Abstract][Full Text] [Related]
8. Carcinomatous meningitis from transitional cell carcinoma of the bladder: case report.
Hussein AM; Savaraj N; Feun LG; Ganjei P; Donnelly E
J Neurooncol; 1989 Sep; 7(3):255-60. PubMed ID: 2795119
[TBL] [Abstract][Full Text] [Related]
9. Adjuvant chemotherapy for invasive urothelial cancer: experience with a methotrexate, vincristine, cisplatin, cyclophosphamide, adriamycin and bleomycin (MVP-CAB) regimen: a preliminary report.
Gohji K; Higuchi A; Maruyama S; Minayoshi K; Fujii A; Itoh N; Hasunuma Y; Tanaka H; Izumi T
Jpn J Clin Oncol; 1993 Oct; 23(5):291-8. PubMed ID: 7693990
[TBL] [Abstract][Full Text] [Related]
10. [Carcinomatous meningitis: rare complication of bladder cancer].
Hasbini A; Himberlin C; Beguinot I; Bonnet-Gausserand F; Coninx P
Rev Med Interne; 1997; 18(5):402-6. PubMed ID: 9183449
[TBL] [Abstract][Full Text] [Related]
11. Meningeal carcinomatosis as the first manifestation of a transitional cell carcinoma of the bladder.
Bruna J; Rojas-Marcos I; Martínez-Yelamos S; Català I; Vidaller A; Galán C; Krupinski J; Rubio F
J Neurooncol; 2003 May; 63(1):63-7. PubMed ID: 12814256
[TBL] [Abstract][Full Text] [Related]
12. [Meningeal carcinomatosis in bladder tumor].
Loizaga Iriarte A; Arciniega García JM; Infante Riaño R; Ullate Jaime V; García Sastre E; Flores Corral N
Actas Urol Esp; 1999; 23(10):873-5. PubMed ID: 10670130
[TBL] [Abstract][Full Text] [Related]
13. Neoadjuvant methotrexate, vinblastine, doxorubicin, and cisplatin for locally advanced transitional cell carcinoma of the bladder.
Miller RJ; Bahnson RR; Banner B; Ernstoff MS; O'Donnell WF
Cancer; 1990 Jan; 65(2):207-10. PubMed ID: 2295043
[TBL] [Abstract][Full Text] [Related]
14. Solitary meningeal recurrence in a patient with transitional cell carcinoma of the bladder with locally bulky disease at presentation.
Santarossa S; Vaccher E; Balestreri L; Volpe R; Tirelli U
J Neurooncol; 1997 Nov; 35(2):141-3. PubMed ID: 9266450
[TBL] [Abstract][Full Text] [Related]
15. Prolonged remission in a patient with transitional cell carcinoma of the bladder developing brain metastases after systemic chemotherapy: a case report.
Jankevicius F; Sruogis A; Ulys A; Zykus A; Sumauskas R
Tumori; 2004; 90(4):420-1. PubMed ID: 15510987
[TBL] [Abstract][Full Text] [Related]
16. [M-VAC chemotherapy for patients with lymph node metastases and/or locally advanced bladder carcinoma].
Igawa M; Ueki T; Ueda M; Okada K; Usui T; Ohnishi Y; Nakatsu H; Kume T; Kodama M; Masu C
Hinyokika Kiyo; 1989 Aug; 35(8):1323-7. PubMed ID: 2683648
[TBL] [Abstract][Full Text] [Related]
17. Methotrexate, vinblastine, adriamycin and cisplatin (MVAC) chemotherapy for the treatment of advanced bladder carcinoma.
Balbay MD; Ozen H; Uluçay S; Sahin A; Ergen A; Koçal C; Remzi D
Int Urol Nephrol; 1993; 25(4):351-7. PubMed ID: 8276565
[TBL] [Abstract][Full Text] [Related]
18. Neurological deficit as the first manifestation of vesical transitional cell carcinoma.
Rastogi R; Singh AK; Rastogi UC; Mohan C; Rastogi V
Saudi J Kidney Dis Transpl; 2011 Sep; 22(5):1022-5. PubMed ID: 21912039
[TBL] [Abstract][Full Text] [Related]
19. Metastatic non-muscle invasive bladder cancer with meningeal carcinomatosis: case report of an unexpected response.
Teyssonneau D; Daste A; Dousset V; Hoepffner JL; Ravaud A; Gross-Goupil M
BMC Cancer; 2017 May; 17(1):323. PubMed ID: 28494780
[TBL] [Abstract][Full Text] [Related]
20. Neoadjuvant M-VAC (methotrexate, vinblastine, doxorubicin, and cisplatin) for infiltrating transitional cell carcinoma of the bladder.
Sternberg CN; Arena MG; Calabresi F; De Carli P; Platania A; Zeuli M; Giannarelli D; Cancrini A; Pansadoro V
Cancer; 1993 Sep; 72(6):1975-82. PubMed ID: 8364877
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
